ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 19:27
ACADIA Pharmaceuticals Price : 29.63 for Aug. 24, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | 29.08 | 29.62 | 28.80 | 29.50 | 1.094M |
| Aug 20, 2026 | 30.00 | 30.00 | 28.95 | 29.04 | 1.319M |
| Aug 19, 2026 | 30.66 | 30.96 | 30.07 | 30.21 | 2.288M |
| Aug 18, 2026 | 29.14 | 30.25 | 29.05 | 30.18 | 2.054M |
| Aug 17, 2026 | 28.63 | 29.03 | 28.21 | 29.01 | 1.122M |
| Aug 14, 2026 | 28.26 | 28.42 | 27.90 | 28.24 | 1.063M |
| Aug 13, 2026 | 29.75 | 29.75 | 28.36 | 28.38 | 1.507M |
| Aug 12, 2026 | 29.18 | 29.85 | 28.83 | 29.45 | 1.410M |
| Aug 11, 2026 | 29.56 | 29.76 | 29.10 | 29.41 | 1.347M |
| Aug 10, 2026 | 29.00 | 29.65 | 29.00 | 29.39 | 2.726M |
| Aug 07, 2026 | 28.57 | 29.29 | 28.20 | 29.21 | 1.783M |
| Aug 06, 2026 | 28.85 | 29.48 | 28.32 | 28.45 | 3.050M |
| Aug 05, 2026 | 27.96 | 29.16 | 27.80 | 28.80 | 4.549M |
| Aug 04, 2026 | 25.66 | 27.23 | 25.55 | 27.15 | 2.440M |
| Aug 03, 2026 | 25.96 | 26.10 | 25.43 | 25.61 | 1.368M |
| Jul 31, 2026 | 26.44 | 26.44 | 25.34 | 25.87 | 1.534M |
| Jul 30, 2026 | 26.13 | 26.58 | 25.87 | 26.55 | 1.299M |
| Jul 29, 2026 | 26.12 | 26.54 | 25.82 | 26.34 | 1.733M |
| Jul 28, 2026 | 25.52 | 26.08 | 25.52 | 26.01 | 940899.0 |
| Jul 27, 2026 | 25.22 | 25.78 | 24.99 | 25.39 | 1.400M |
| Jul 24, 2026 | 24.90 | 25.10 | 24.57 | 24.84 | 1.047M |
| Jul 23, 2026 | 24.23 | 25.00 | 24.23 | 24.83 | 1.272M |
| Jul 22, 2026 | 25.62 | 25.62 | 24.91 | 24.96 | 1.163M |
| Jul 21, 2026 | 25.20 | 25.57 | 25.07 | 25.43 | 1.341M |
| Jul 20, 2026 | 26.07 | 26.16 | 25.03 | 25.09 | 1.487M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Incyte Corp. | 127.99 |
| Agios Pharmaceuticals, Inc. | 32.60 |
| Biogen, Inc. | 218.11 |
| Insmed, Inc. | 124.03 |
| Vertex Pharmaceuticals, Inc. | 547.74 |
Price Related Metrics
| PE Ratio | 13.34 |
| PS Ratio | 4.473 |
| PEG Ratio | 0.1997 |
| Price to Book Value | 3.903 |
| Price to Free Cash Flow | 34.97 |
| Earnings Yield | 7.49% |
| Market Cap | 5.100B |
| PEGY Ratio | 0.1997 |
| Operating PE Ratio | 58.97 |
| Normalized PE Ratio | 13.34 |